Proteolytic host cell enzymes in gingival crevice fluid

Periodontology 2000

Volumn 31, Issue , 2003, Pages 77-104

  Uitto, Veli Jukka ^a,b   Overall, Christopher M ^c   McCulloch, Christopher ^d  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CATHEPSIN G; CELL ENZYME; COLLAGEN; HEMOPEXIN; ISOPROTEIN; LEUKOCYTE ELASTASE; MATRIX METALLOPROTEINASE; MYELOBLASTIN; NEUTRAL PROTEINASE; PLASMINOGEN ACTIVATOR; TISSUE INHIBITOR OF METALLOPROTEINASE; CATHEPSIN; COLLAGENASE; ENZYME PRECURSOR; PEPTIDE HYDROLASE; SERINE PROTEINASE; UROKINASE;

CATALYSIS; CYTOPLASM; DENTAL CARE; DISEASE COURSE; ENZYME ACTIVITY; ENZYME STRUCTURE; EPITHELIUM CELL; FIBROBLAST; GINGIVITIS; HOST CELL; HUMAN; IMMUNOLOGICAL PROCEDURES; INFLAMMATION; NEUTROPHIL; PERIODONTAL DISEASE; PERIODONTICS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; REGULATORY MECHANISM; REVIEW; CLASSIFICATION; ENZYMOLOGY; IMMUNOASSAY; METABOLISM;

CATHEPSINS; COLLAGEN; COLLAGENASES; ENZYME PRECURSORS; EPITHELIAL CELLS; FIBROBLASTS; GINGIVAL CREVICULAR FLUID; HEMOPEXIN; HUMANS; IMMUNOASSAY; INFLAMMATION; LEUKOCYTE ELASTASE; MATRIX METALLOPROTEINASES; MYELOBLASTIN; NEUTROPHILS; PEPTIDE HYDROLASES; PERIODONTAL INDEX; PLASMINOGEN ACTIVATORS; SERINE ENDOPEPTIDASES; TISSUE INHIBITOR OF METALLOPROTEINASES; URINARY PLASMINOGEN ACTIVATOR;

EID: 0037270522     PISSN: 09066713     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0757.2003.03106.x     Document Type: Review

References (221)

1. Abe M, Kawamoto K, Okamoto H, Horiuchi N. Induction of collagenase-2 (matrix metalloproteinase-8) gene expression by interleukin-1beta in human gingival fibroblasts. J Periodontal Res 2001: 36: 153-159.
2. Aiba T, Akeno N, Kawane T, Okamoto H, Horiuchi N. Matrix metalloproteinases-1 and -8 and TIMP-1 mRNA levels in normal and diseased human gingivae. Eur J Oral Sci 1996: 104: 562-569.
3. Alexander MB, Damoulis PD. The role of cytokines in the pathogenesis of periodontal disease. Curr Opin Periodontol 1994: 39-53.
4. Alfano MC. The origin of gingival fluid. J Theor Biol 1974: 47: 127-136.
5. Allan JA, Docherty AJ, Barker PJ, Huskisson NS, Reymolds JJ, Murphy G. Binding of gelatinases A and B to type-I collagen and other matrix components. Biochem J 1995: 309: 299-306.
6. Ambrose WP, Semin DJ, Robbins DL, Van Orden A, Kashem MA, Hamilton SA, Nelson RM, Jett JH, Keller RA Detection system for reaction-rate analysis in a low-volume proteinase-inhibition assay. Anal Biochem 1998: 263: 150-157.
7. Armitage GC, Jeffcoat MK, Chadwick DE, Taggart EJ Jr, Numabe Y, Landis JR, Weaver SL, Sharp TJ. Longitudinal evaluation of elastase as a marker for the progression of periodontitis. J Periodontol 1994: 65: 120-128.
8. Attström R, Egelberg J. Emigration of blood neutrophils and monocytes into the gingival crevices. J Periodontal Res 1970: 5: 48-55.
9. Ayasaka N, Goto T, Tsukuba T, Kido MA, Nagata E, Kondo T, Yamamoto K, Tanaka T. Immunocytochemical localization of cathepsin D in rat junctional epithelium. J Dent Res 1993: 72: 502-507.
10. Baggiolini M. Chemokines in pathology and medicine. J Intern Med 2001: 250: 91-10.
11. Banyai L, Patthy L. Evidence for the involvement of type II domains in collagen binding by 72 kDa type IV procollagenase. FEBS Lett 1991: 282: 23-25.
12. Banyai L, Tordai H, Patthy L. The gelatin-binding site of human 72 kDa type IV collagenase (gelatinase A). Biochem J 1994: 298: 403-407.
13. Banyai L, Trexler M, Koncz S, Gyenes M, Sipos G, Patthy L. The collagen-binding site of type-II units of bovine seminal fluid protein PDC-109 and fibronectin. Eur J Biochem 1990: 193: 801-806.
14. Bechtel MJ, Reinartz J, Rox JM, Inndorf S, Schaefer BM, Kramer MD. Upregulation of cell-surface-associated plasminogen activation in cultured keratinocytes by interleukin-1 beta and tumor necrosis factor-alpha. Exp Cell Res 1996: 223: 395-404.
15. Bedard M, McClure CD, Schiller NL, Francoeur C, Cantin A, Denis M. Release of interleukin-8, interleukin-6, and colony-stimulating factors by upper airway epithelial cells: implications for cystic fibrosis. Am J Respir 1993: 9: 455-462.
16. Belaaouaj A, McCarthy R, Baumann M, Gao Z, Ley TJ, Abraham SN, Shapiro SD. Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis. Nat Med 1998: 4: 615-618.
17. Bennick A, Hunt AM. Collagenolytic activity in oral tissues. Arch Oral Biol 1967: 12: 1-10.
18. Bhide VM, Smith L, Overall CM, Birek P, McCulloch CA. Use of a fluorogenic septapeptide matrix metalloproteinase assay to assess responses to periodontal treatment. J Periodontol 2000: 71: 690-700.
19. Bigg HF Clark IM, Cawston TE. Fragments of human fibroblast collagenase interaction with metalloproteinase inhibitors and substrates. Biochem Biophys Acta 1994: 1208: 157-165.
20. Birek P, McCulloch CA, Overall CM. Measurements of probing velocity with an automated periodontal probe and the relationship with experimental periodontitis in the Cynomolgus monkey (Macaca fascicularis). Arch Oral Biol 1989: 34: 793-801.
21. Bode W, Reinemer A, Huber R, Kleine T, Schnierer S, Tschesche H. The X-ray crystal structure of the catalytic domain of human neutrophil collagenase inhibited by a substrate analogue reveals the essentials for catalysis and specificity. EMBO J 1994: 13: 1263-1269.
22. Borkakoti N, Winkler FK, Williams DH, D'Arcy A, Broadhurst MJ, Brown PA, Johnson WH, Murray EJ. Structure of human fibroblast collagenase complexed with an inhibitor. Nature Struct Biol 1994: 1: 106-110.
23. Borregaard N, Kjeldsen L, Lollike K, Sengelov H. Granules and secretory vesicles of the human neutrophil. Clin Exp Immunol 1995: 101: 6-9.
24. Borregaard N. Current concepts about neutrophil granule physiology. Curr Opin Hematol 1996: 3: 11-18.
25. Bowers JE, Zahradnik RT. Evaluation of a chairside gingival protease test for use in periodontal diagnosis. J Clin Dent 1989: 1: 106-109.
26. Brew K, Dinakarpandian D, Nagase H. Tissue inhibitor of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 2000: 7: 267-283.
27. Brooks PC, Stromblad S, Sanders LC, von Schalscha TL, Aimes RT, Stetler-Stevenson WG, Quigley JP, Cheresh DA. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell 1996: 85: 683-693.
28. Carmeliet P, Collen D. Development and disease in proteinase-deficient mice. Role of the plasminogen, matrix metalloproteinase and coagulation system. Thromb Res 1998: 15: 255-285.
29. Chambers DA, Imrey PB, Cohen RL, Crawford JM, Alves ME, McSwiggin TA. Longitudinal study of aspartate aminotransferase in human gingival crevicular fluid. J Periodontal Res 1991: 26: 65-74.
30. Chen HY, Cox SW, Eley BM, Mantyla P, Ronka H, Sorsa T. Matrix metalloproteinase-8 levels and elastase activities in gingival crevicular fluid from chronic adult periodontitis patients. J Clin Periodontol 2000: 27: 366-369.
31. Chidwick K, Whichelow CE, Zhang Z, Fairburn K, Sachs JA, Blake DR, Winyard PG. Relationship between alpha 1-antitrypsin inactivation and tumor necrosis factor alpha concentration in the synovial fluid of patients with rheumatoid arthritis. Arthritis Rheum 1994: 37: 1723-1726.
32. Cimasoni G. The crevicular fluid. Monogr Oral Sci 1974: 3: 1-122.
33. Clark IM, Cawston TE. Fragments of human fibroblast collagenase. Purification and characterization. Biochem J 1989: 263: 201-206.
34. Coeshott C, Ohnemus C, Pilyavskaya A, Ross S, Wieczorek M, Kroona H, Leimer AH, Cheronis J. Converting enzyme-independent release of tumor necrosis factor alpha and IL-1beta from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase 3. Proc Natl Acad Sci USA 1999: 96: 6261-6266.
35. Collier EE, Krasnov PA, Strongin AY, Birkedal-Hansen H, Goldberg GI. Alanine scanning mutagenesis and functional analysis of the fibronectin-like collagen-binding domain from human 92-kDa type IV collagenase. J Biol Chem 1992: 267: 6776-6781.
36. Collier IE, Wilhelm SM, Eisen AZ, Mariner BL, Grant GA, Seltzer JL, Kronberger A, He CS, Bauer EA, Goldberg GI. H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J Biol Chem 1988: 263: 6579-6587.
37. Cox SW, Eley BM. Cathepsin B/L-, elastase-, tryptase-, trypsin- and dipeptidyl peptidase IV-like activities in gingival crevicular fluid. A comparison of levels before and after basic periodontal treatment of chronic periodontitis patients. J Clin Periodontol 1992: 19: 333-339.
38. Crystal RG. Alpha 1-antitrypsin deficiency: pathogenesis and treatment. Hosp Pract (Off ed) 1991: 26, 81-84.
39. Dahan M, Nawrocki B, Elkaim R, Soell M, Bolcato-Bellemin A-L, Birembaut P, Tenenbaum H. Expression of matrix metalloproteinases in healthy and diseased human gingiva. J Clin Periodont 2001: 28: 128-136.
40. Dahan M, Nawrocki B, Elkaim R, Soell M, Bolcato-Bellemin AL, Birembaut P, Tenenbaum H. Expression of matrix metalloproteinases in healthy and diseased human gingiva. J Clin Periodontol 2001: 28: 128-136.
41. Dallegri F, Ottonello L. Tissue injury in neutrophilic inflammation. Inflamm Res 1997: 46: 382-391.
42. DeCarlo AA, Windsor LJ, Bodden MK, Harber GJ, Birkedal-Hansen B, Birkedal-Hansen H. Activation and novel processing of matrix metalloproteinases by a thiol-proteinase from the oral anaerobe Porphyromonas gingivalis. J Dent Res 1997: 76: 1260-1270.
43. Ding Y, Uitto VJ, Haapasalo M, Lounatmaa K, Konttinen YT, Salo T, Grenier D, Sorsa T. Membrane components of Treponema denticola trigger proteinase release from human polymorphonuclear leukocytes. J Dent Res 1996: 75: 1986-1993.
44. Doring G. Serine proteinase inhibitor therapy in alpha (1) -antitrypsin inhibitor deficiency and cystic fibrosis. Pediatr Pulmonol 1999: 28: 363-375.
45. Drouin L, Overall CM, Sodek J. Identification of matrix metalloendoproteinase inhibitor (TIMP) in human parotid and submandibular saliva, partial purification and characterization. J Periodontal Res 1988: 23: 370-377.
46. Dunsmore SE, Saarialho-Kere UK, Roby JD, Wilson CL, Matrisian LM, Welgus HG, Parks WC. Matrilysin expression and function in airway epithelium. J Clin Invest 1998: 102: 1321-1331.
47. Egelberg J. Permeability of the dento-gingival blood vessels. 1. Application of the vascular labelling method and gingival fluid measurements. J Periodontal Res 1966: 1: 1801-1891.
48. Eley BM, Cox SW. Advances in periodontal diagnosis. 8. Commercial diagnostic kits based on GCF proteolytic and hydrolytic enzyme levels. Br Dent J 1998: 184: 373-376.
49. Engel J. Domains in proteins and proteoglycans of the extracellular matrix with functions in assembly and cellular activities. Int J Biol Macromol 1991: 13: 147-151.
50. Everts V, van der Zee E, Creemers L, Beertsen W. Phagocytosis and intracellular digestion of collagen, its role in turnover and remodelling. Histochem J 1996: 28: 229-245.
51. Fields BB, Van Wart HE, Birkedal-Hansen H. Sequence specificity of human skin fibroblast collagenase. Evidence for the role of collagen structure in determining the collagenase cleavage site. J Biol Chem 1987: 262: 6221-6226.
52. Fiers W. Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level. FEBS Lett 1991: 285: 199-212.
53. Firth JD, Putnins EE, Larjava H, Uitto VJ. Bacterial phospholipase C upregulates matrix metalloproteinase expression by cultured epithelial cells. Infect Immun 1997: 65: 4931-4936.
54. Firth JD, Sue ES, Putnins EE, Oda D, Uitto VJ. Chymotrypsin-like enzyme secretion is stimulated in cultured epithelial cells during proliferation and in response to Actinobacillus actinomycetemcomitans. J Periodontal Res 1996: 31: 345-354.
55. Friedberg MH, Glantz MJ, Klempner MS, Cole BF, Perides G. Specific matrix metalloproteinase profiles in the cerebrospinal fluid correlated with the presence of malignant astrocytomas, brain metastases, and carcinomatous meningitis. Cancer 1998: 82: 923-930.
56. Fullmer HM, Gibson W. Collagenolytic activity in gingivae of man. Nature 1966: 209: 728-729.
57. Gangbar S, Overall CM, McCulloch CA, Sodek J. Identification of polymorphonuclear leukocyte collagenase and gelatinase activities in mouthrinse samples. Correlation with periodontal disease activity in adult and juvenile periodontitis. J Periodontal Res 1990: 25: 257-267.
58. Ganz T, Lehrer RI. Defensin. Curr Opin Immunol 1994: 6: 584-589.
59. Gerber A, Wille A, Welte T, Ansorge S, Buhling F. Interleukin-6 and transforming growth factor-beta 1 control expression of cathepsins B and L in human lung epithelial cells. J Interferon Cytokine Res 2001: 21: 11-19.
60. Giannelli G, Falk-Marzillier J, Schiraldi O, Stetler-Stevenson WG, Quaranta V. Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science 1997: 277: 225-228.
61. Gohlke U, Gomis-Rüth F-Z, Crabbe T, Murphy G, Docherty AJP, Bode W. The C-terminal (haemopexin-like) domain structure of human gelatinase A (MMP2): structural implications for its function. FEBS Lett 1996: 378: 126-130.
62. Golub LM, Kleinberg I. Gingival crevicular fluid: a new diagnostic aid in managing the periodontal patient. Oral Sci Rev 1976: 8: 49-61.
63. Golub LM, Lee HM, Greenwald RA, Ryan ME, Sorsa T, Salo T, Giannobile WV. A matrix metalloproteinase inhibitor reduces bone-type collagen degradation fragments and specific collagenases in gingival crevicular fluid during adult periodontitis. Inflamm Res 1997: 46: 310-319.
64. Golub LM, Siegel K, Ramamurthy NS, Ramamurthy NS, Mandel ID. Some characteristics of collagenase activity in gingival crevicular fluid and its relationship to gingival diseases in humans. J Dent Res 1976: 55: 1049-1057.
65. Golub LM, Stakiw JE, Singer DL. Collagenolytic activity of human gingival crevice fluid. J Dent Res 1974: 53: 1501.
66. Golub LM, Stakiw JE, Singer DL. Collagenolytic activity of human gingival crevice fluid. J Dent Res 1974: 53: 1501.
67. Gomis-Rüth FX, Gohlke U, Betz M, Knauper V, Murphy G, Lopez-Otin C, Bode W. The helping hand of collagenase-3 (MMP-13). 2.7 A crystal structure of its C-terminal haemopexin-like domain. J Mol Biol 1996: 264: 556-566.
68. Gustafsson A, Asman B, Bergstrom K. Elastase and lactoferrin in gingival crevicular fluid: possible indicators of a granulocyte-associated specific host response. J Periodontal Res 1994: 29: 276-282.
69. Hara K, Takahashi T. Hydroxyproline content in gingival exudate before and after periodontal surgery. J Periodontal Res 1975: 10: 270-274.
70. Haro H, Crawford HC, Fingleton B, Shinomiya K, Spengler DM, Matrisian LM. Matrix metalloproteinase-7-dependent release of tumor necrosis factor-alpha in a model of herniated disc resorption. J Clin Invest 2000: 105: 143-150.
71. Hart TC, Hart PS, Michalec MD, Zhang Y, Marazita ML, Cooper M, Yassin OM, Nusier M, Walker S. Localisation of a gene for prepubertal periodontitis to chromosome 11q14 and identification of a cathepsin C gene mutation. J Med Genet 2000: 37: 95-101.
72. Hirose T, Patterson C, Pourmotabbed T, Mainardi CL, Hasty KA. Structure-function relationship of human neutrophil collagenase: identification of regions responsible for substrate specificity and general proteinase activity. Proc Natl Acad Sci USA 1993: 90: 2569-2573.
73. Hotary K, Allen E, Punturieri A, Yana I, Weiss SJ. Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2 and 3. J Cell Biol 2000: 149: 1309-1323.
74. Huhtala P, Humphries MJ, McCarthy JB, Tremble PM, Werb Z, Damsky CH. Cooperative signaling by alpha 5 beta 1 and alpha 4 beta 1 integrins regulates metalloproteinase gene expression in fibroblasts adhering to fibronectin. J Cell Biol 1995: 129: 867-879.
75. Ingham KC, Brew SA, Migliorini MM. Further localization of the gelatin-binding determinants within fibronectin. Active fragments devoid of type II homologous repeat modules. J Biol Chem 1989: 264: 16977-16980.
76. Ingman T, Sorsa T, Michaelis J, Konttinen YT. Immunohistochemical study of neutrophil- and fibroblast-type collagenases and stromelysin-1 in adult periodontitis. Scand J Dent Res 1994: 102: 342-349.
77. Ingman T, Tervahartiala T, Ding Y, Tschesche H, Haerian A, Kinane DF, Konttinen YT, Sorsa T. Matrix metalloproteinases and their inhibitors in gingival crevicular fluid and saliva of periodontitis patients. J Clin Periodontol 1996: 23: 1127-1132.
78. Johansson N, Airola K, Grenman R, Kariniemi AL, Saarialho-Kere U, Kähäri VM. Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck. Am J Pathol 1997: 151: 499-508.
79. Kähäri VM, Saarialho-Kere U. Matrix metalloproteinases in skin. Exp Dermatol 1997: 6: 199-213.
80. Kaplan AP, Ghebrehiwet B, Silverberg M, Sealey JE. The intrinsic coagulation-kinin pathway, complement cascades, plasma renin-angiotensin system, and their interrelationships. Crit Rev Immunol 1981: 3: 75-93.
81. Keski-Oja J, Lohi J, Tuuttila A, Tryggvason K, Vartio T. Proteolytic processing of the 72,000-Da type IV collagenase by urokinase plasminogen activator. Exp Cell Res 1992: 202: 471-476.
82. Knauper V, Docherty AJP, Smith B, Tschesche H, Murphy G. Analysis of the contribution of the hinge region of human neutrophil collagenase (HNC, MMP-8) to stability and collagenolytic activity by alanine scanning mutagenesis. FEBS Lett 1997: 405: 60-64.
83. Knauper V, Cowell S, Smith B, Lopez-Otin C, O'Shea M, Morris H, Zardi L, Murphy G. The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction. J Biol Chem 1997: 272: 7608-7616.
84. Knauper V, Murphy G, Tschesche H. Neutrophil procollagenase can be activated by stromelysin-2. Ann N Y Acad Sci 1994: 732: 367-368.
85. Knebel NG, Sharp SR, Madigan MJ. Rapid quantitative determination of a collagenase inhibitor and its major metabolite by on-line liquid chromatography with ionspray tandem mass spectrometric detection. J Chromatogr B Biomed Appl 1995: 673: 213-222.
86. Korostoff JM, Wang JF, Sarment DP, Stewart JC, Feldman RS, Billings PC. Analysis of in situ protease activity in chronic adult periodontitis patients, expression of activated MMP-2 and a 40 kDa serine protease. J Periodontol 2000: 71: 353-360.
87. Koshiba T, Hosotani R, Wada M, Miyamoto Y, Fujimoto K, Lee JU, Doi R, Arii S, Imamura M. Involvement of matrix metalloproteinase-2 activity in invasion and metastasis of pancreatic carcinoma. Cancer 1998: 82: 642-650.
88. Lamster IB, Harper DS, Goldstein S, Celenti RS, Oshrain RL. The effect of sequential sampling on crevicular fluid Volume and enzyme activity. J Clin Periodontol 1989: 16: 252-258.
89. Lamster IB, Hartley LJ, Vogel RI. Development of a biochemical profile for gingival crevicular fluid. Methodological considerations and evaluation of collagen-degrading and ground substance-degrading enzyme activity during experimental gingivitis. J Periodontol 1985:56(11 Suppl.): 13-21.
90. Lamster IB, Holmes LG, Gross KB, Cohen DW, Rose LF, Peters LM, Pope MR. The relationship of beta-glucuronidase activity in crevicular fluid to clinical parameters of periodontal disease. Findings from a multicenter study. J Clin Periodontol 1994: 21: 118-127.
91. Lamster IB, Holmes LG, Gross KB, Oshrain RL, Cohen DW, Rose LF, Peters LM, Pope, MR. The relationship of beta-glucuronidase activity in crevicular fluid to probing attachment loss in patients with adult periodontitis. Findings from a multicenter study. J Clin Periodontol 1995: 22: 36-44.
92. Lamster IB, Oshrain RL, Gordon JM. Enzyme activity in human gingival crevicular fluid: considerations in data reporting based on analysis of individual crevicular sites. J Clin Periodontol 1986: 13: 799-804.
93. Lamster IB, Vogel RI, Hartley LJ, DeGeorge CA, Gordon JM. Lactate dehydrogenase, beta-glucuronidase and arylsulfatase activity in gingival crevicular fluid associated with experimental gingivitis in man. J Periodontol 1985: 56: 139-147.
94. Lamster IB. Evaluation of components of gingival crevicular fluid as diagnostic tests. Ann Periodontol 1997: 2: 123-137.
95. Le J, Dauchot P, Perrot JL, Cambazard F, Frey J, Chamson A. Quantitative zymography of matrix metalloproteinases by measuring hydroxyproline: application to gelatinases A and B. Electrophoresis 1999: 20: 2824-2829.
96. Leber TM, Balkwill FR. Zymography: a single-step staining method for quantitation of proteolytic activity on substrate gels. Anal Biochem 1997: 249: 24-28.
97. Lee W, Aitken S, Sodek J, McCulloch CA. Evidence of a direct relationship between neutrophil collagenase activity and periodontal tissue destruction in vivo: role of active enzyme in human periodontitis. J Periodontal Res 1995: 30: 23-33.
98. Lefevere MF, Slegers GA, Claeys AE. Evaluation of a rapid, sensitive and specific assay for the determination of collagenolytic activity in biological samples. Clin Chim Acta 1979: 92: 167-175.
99. Lein M, Nowak L, Jung K, Koenig F, Lichtinghagen R, Schnorr D, Loening SA. Analytical aspects regarding the measurement of metalloproteinases and their inhibitors in blood. Clin Biochem 1997: 30: 491-496.
100. Li J, Brick P, O'Hare MC, Skarzynski T, Lloyd LF, Curry VA, Clark IM, Bigg HF, Hazleman BL, Cawston TE, Blow DM. Structure of full-length porcine synovial collagenase reveals a C-terminal domain containing a calcium-linked, four-bladed beta-propeller. Structure 1995: 3: 541-549.
101. Libson AM, Gittis AG, Collier IE, Marmer BL, Goldberg GI, Lattman EE. Crystal structure of the haemopexin-like C-terminal domain of gelatinase A. Nature Struct Biol 1995: 2: 938-942.
102. Listgarten MA. Electron microscopic study of the gingivodental junction of man. Am J Anat 1966: 119: 147-177.
103. Löe H. Physiology of the gingival pocket. Acad Rev Calif Acad Periodontol 1965: 13: 6-14.
104. Lopez-Otin C, Overall CM. Protease degradomics: a new challenge for proteomics. Nat Rev Mol Cell Biol 2002: 3: 509-519.
105. Lovejoy B, Cleasby A, Hassell AM, Longley K, Luther MA, Weigl D, McGeehan G, McElroy AB, Drewry D, Lambert MH, Jordan SR. Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitor. Science 1994: 263: 375-377.
106. Lu PCYeH, Maeda M, Azar DT. Immunolocalization and gene expression of matrilysin during corneal wound healing. Invest Ophthalmol 1999: 40: 20-27.
107. Magnusson I, Persson RG, Page RC, DeRouen TA, Crawford JM, Cohen RL, Chambers DA, Alves ME, Clark WB. A multi-center clinical trial of a new chairside test in distinguishing between diseased and healthy periodontal sites. II. Association between site type and test outcome before and after therapy. J Periodontol 1996: 67: 589-596.
108. Mäkelä M, Larjava H, Pirilä E, Maisi P, Salo T, Sorsa T, Uitto VJ. Matrix metalloproteinase 2 (gelatinase A) is related to migration of keratinocytes. Exp Cell Res 1999: 251: 67-78.
109. Mäkelä M, Salo T, Uitto VJ, Larjava H. Matrix metalloproteinases (MMP-2 and MMP-9) of the oral cavity: cellular origin and relationship to periodontal status. J Dent Res 1994: 73: 1397-1406.
110. Mancini S, Romanelli R, Laschinger CA, Overall CM, Sodek J, McCulloch CA. Assessment of a novel screening test for neutrophil collagenase activity in the diagnosis of periodontal diseases. J Periodontol 1999: 70: 1292-1302.
111. Massova I, Fridman R, Mobashery S. Structural insights into the catalytic domains of human matrix metalloproteinaase-2 and human matrix metalloproteinase-9: Implications for substrate specificites. J Mol Model 1997: 3: 17-30.
112. McGeeham GM, Bickett DM, Green M, Kassel D, Wiseman JS, Berman J. Characterization of the peptide substrate specificities of interstitial collagenase and 92-kDa gelatinase. Implications for substrate optimization. J Biol Chem 1994: 269: 32814-32820.
113. McQuibban GA, Gong JH, Wong JP, Wallace JL, Clark-Lewis I, Overall CM. Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. Blood 2002: 100: 1160-1167.
114. McQuibban GA, Gong J-H, Tam E, McCulloch CAG, Clark-Lewis I, Overall CM. Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. Science 2000: 289: 1202-1206.
115. McQuibban GA, Gong J-H, Wallace J, Clark-Lewis I, Overall CM. Monocyte chemokine gradient disruption by matrix metalloproteinase activity. Blood submitted.
116. Mitchell PG, Magna HA, Reeves LM, Lopresti-Morrow LL, Yocum SA, Rosner PJ, Geoghegan KE, Hambor JE. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J Clin Invest 1996: 97: 761-768.
117. Miyasaki KT. The neutrophil: mechanisms of controlling periodontal bacteria. J Periodontol 1991: 62: 761-774.
118. Moser PL, Kieback DG, Hefler L, Tempfer C, Neunteufel W, Gitsch G. Immunohistochemical detection of matrix metalloproteinases (MMP) 1 and 2, and tissue inhibitor of metalloproteinase 2 (TIMP 2) in stage IB cervical cancer. Anticancer Res 1999: 19: 4391-4393.
119. Muller D, Quantin B, Gesnel MC, Millon-Collard R, Abecassis J, Breathnach R. The collagenase gene family in humans consists of at least four members. Biochem J 1988: 253: 187-192.
120. Murphy G, Allan JA, Willenbrock F, Cockett MI, O'Connell JP, Docherty AJP. The role of the C-terminal domain in collagenase and stromelysin specificity. J Biol Chem 1992: 267: 9612-9618.
121. Murphy G, Nguyen Q, Cockett MI, Atkinson SJ, Allan JA, Knight CG, Willenbrock F, Docherty AJP. Assessment of the role of the fibronectin-like domain of gelatinase A by analysis of a deletion mutant. J Biol Chem 1994: 269: 6632-6636.
122. Murphy G, Stanton H, Cowell S, Butler G, Knauper V, Atkinson S, Gavrilovic J. Mechanisms for pro matrix metalloproteinase activation. APMIS 1999: 107: 38-44.
123. Murphy G, Willenbrock F, Ward RV, Cockett MI, Eaton D, Docherty AJP. The C-terminal domain of 72 kDa gelatinase A is not required for catalysis, but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloproteinases. Biochem J 1992: 283: 637-641.
124. Nagase H, Fields CG, Fields GB. Design and characterization of a fluorogenic substrate selectively hydrolyzed by stromelysin 1 (matrix metalloproteinase-3). J Biol Chem 1994: 269: 20952-10957.
125. Nahori MA, Renesto P, Vargaftig BB, Chignard M. Activation and damage of cultured airway epithelial cells by human elastase and cathepsin G. Eur J Pharmacol 1992: 228: 213-218.
126. Netzel-Arnett S, Fields GB, Birkedal-Hansen H, Van Wart HE. Sequence specificities of human fibroblast and neutrophil collagenases. J Biol Chem 1991: 266: 6747-6755.
127. Netzel-Arnett S, Sang QX, Moore WG, Navre M, Birkedal-Hansen H, Van Wart HE. Comparative sequence specificities of human 72- and 92-kDa gelatinases (type IV collagenases) and PUMP (matrilysin). Biochemistry 1993: 32: 6427-6432.
128. Nomura T, Takahashi T, Hara K. Expression of TIMP-1, TIMP-2 and collagenase mRNA in periodontitis-affected human gingival tissue. J Periodontal Res 1993: 28: 354-362.
129. O'Farrell TJ, Pourmotabbed T. The fibronectin-like domain is required for the type V and XI collagenolytic activity of gelatinase B. Arch Biochem Biophys 1998: 354: 24-30.
130. Ohlsson K, Olsson I. The neutral proteases of human granulocytes. Isolation and partial characterization of two granulocyte collagenases. Eur J Biochem 1973: 36: 473-481.
131. Oliver GW, Leferson JD, Stetler-Stevenson WG, Kleiner DE. Quantitative reverse zymography: analysis of picogram amounts of metalloproteinase inhibitors using gelatinase A and B reverse zymograms. Anal Biochem 1997: 244: 161-166.
132. Olsen MW, Toth M, Gervasi DC, Sado Y, Ninomiya Y, Fridman R. High affinity binding of latent matrix metalloproteinase-9 to the alpha 2 (IV) chain of collagen IV. J Biol Chem 1998: 273: 10672-10681.
133. Overall CM, King AE, Sam DK, Ong AD, Lau TTY, Wallon UM, DeClerck YA, Atherstone J. Identification of the tissue inhibitor of metalloproteinases-2 (TIMP-2) binding site on the hemopexin carboxyl domain of human gelatinase A by site-directed mutagenesis. The hierarchical role in binding TIMP-2 of the unique cationic clusters of hemopexin modules III and IV. J Biol Chem 1999: 274: 4421-4429.
134. Overall CM, Lowne D, Wells G, Burel S, McCullouch CAG, Clements JM. Cloning, CHO cell expression, and activation of rat collagenase-2 (MMP-8). J Dent Res 1999: 78: (IADR Abstracts) 458.
135. Overall CM, Sodek J, McCulloch CA, Birek PB. Evidence for polymorphonuclear leukocyte collagenase and 92-kilodalton gelatinase in gingival crevicular fluid. Infect Immun 1991: 59: 4687-4692.
136. Overall CM, Sodek J. Reciprocal regulation of collagenase, 72 kDa-gelatinase, and TIMP gene expression and protein synthesis in human fibroblasts induced by concanavalin A. Matrix Suppl 1992: 1: 209-211.
137. Overall CM, Tam E, McQuibban GA, Morrison C, Wallon UM, Bigg HF, King AE, Roberts CR. Domain interactions in the gelatinase A:TIMP-2:MT1-MMP activation complex. The ectodomain of the 44-kDa form of membrane type-1 matrix metalloproteinase does not modulate gelatinase A activation. J Biol Chem 2000: 275: 39497-39505.
138. Overall CM, Wallon UM, Steffensen B, De Clerk Y, Tschesche H, Abbey R. Substrate and TIMP interactions with human gelatinase A recombinant COOH-terminal hemopexin-like and fibronectin type-II-like domains. Both the N-and C-domains of TIMP-2 bind the C-domain of gelatinase A. In: Edwards D, Hawkes S, Kokha R, editors. Inhibitors of matrix metalloproteinases in development and disease. Amsterdam: Gordon and Breach, 2000: 57-69.
139. Owen CA, Campbell EJ. The cell biology of leukocyte-mediated proteolysis. J Leukoc Biol 1999: 65: 137-150.
140. Owens RJ, Baralle FE. Mapping the collagen-binding site of human fibronectin by expression in Escherichia coli. EMBO J 1986: 5: 2825-2830.
141. Pan YM, Firth JD, Salonen JI, Uitto VJ. Multilayer culture of periodontal ligament epithelial cells: a model for junctional epithelium. J Periodontal Res 1995: 30: 97-107.
142. Park HI, Ni J, Gerkema FE, Liu D, Belozerov VE, Sang QX. Identification and characterization of human endometase (Matrix metalloproteinase-26) from endometrial tumor. J Biol Chem 2000: 275: 20540-20544.
143. Pei D, Weiss SJ. Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity. J Biol Chem 1996: 271: 9135-9140.
144. Persson GR, Page RC. Effect of sampling time and repetition on gingival crevicular fluid and aspartate aminotransferase activity. J Periodontal Res 1990: 25: 236-242.
145. Peterson MW, Walter ME, Nygaard SD. Effect of neutrophil mediators on epithelial permeability. Am J Respir Cell Mol Biol 1995: 13: 719-727.
146. Powell WC, Fingleton B, Wilson CL, Boothby M, Matrisian LM. The metalloproteinase matrilysin proteolytically generates active soluble fas ligand and potentiates epithelial cell apoptosis. Curr Biol 1999: 9: 1441-1447.
147. Putnins EE, Firth JD, Lohachitranont A, Uitto VJ, Larjava H. Keratinocyte growth factor (KGF) promotes keratinocyte cell attachment and migration on collagen and fibronectin. Cell Adhes Commun 1999: 7: 211-221.
148. Putnins EE, Firth JD, Uitto VJ. Stimulation of collagenase (matrix metalloproteinase-1) synthesis in histiotypic epithelial cell culture by heparin is enhanced by keratinocyte growth factor. Matrix Biol 1996: 15: 21-29.
149. Pöllänen J, Stephens RW, Vaheri A. Directed plasminogen activation at the surface of normal and malignant cells. Adv Cancer Res 1991: 57: 273-328.
150. Ravanti L, Hakkinen L, Larjava H, Saarialho-Kere U, Foschi M, Han J, Kahari VM. Transforming growth factor-beta induces collagenase-3 expression by human gingival fibroblasts via p38 mitogen-activated protein kinase. J Biol Chem 1999: 274: 37292-37300.
151. Riikonen T, Westermarck J, Koivisto L, Broberg A, Kähäri VM, Heino J. Integrin alpha 2 beta 1 is a positive regulator of collagenase (MMP-1) and collagen alpha 1(I) gene expression. J Biol Chem 1995: 270: 13548-13552.
152. Romanelli R, Mancini S, Laschinger C, Overall CM, Sodek J, McCulloch CAG. Activation of neutrophil collagenase in human periodontitis. Infect Immun 1999: 67: 2319-2326.
153. Ruangpanit N, Chan D, Holmbeck K, Birkedal-Hansen H, Polarek J, Yang C, Bateman JF, Thompson EW. Gelatinase A (MMP-2) activation by skin fibroblasts: dependence on MT1-MMP expression and fibrillar collagen form. Matrix Biol 2001: 20: 193-203.
154. Ryhänen L, Rantala-Ryhänen S, Tan EM, Uitto J. Assay of collagenase activity by a rapid, sensitive, and specific method. Coll Relat Res 1982: 2: 117-130.
155. Saarialho-Kere UK, Crouch EC, Parks WC. Matrix metalloproteinase matrilysin is constitutively expressed in adult human exocrine epithelium. J Invest Dermatol 1995: 105: 190-196.
156. Saarialho-Kere UK. Patterns of matrix metalloproteinase and TIMP expression in chronic ulcers. Arch Dermatol Res 1998: 290: 47-54.
157. Salonen J, Uitto VJ, Pan YM, Oda D. Proliferating oral epithelial cells in culture are capable of both extracellular and intracellular degradation of interstitial collagen. Matrix 1991: 11: 43-55.
158. Schechter NM, Brass LF, Lavker RM, Jensen PJ. Reaction of mast cell proteases tryptase and chymase with protease activated receptors (PARs) on keratinocytes and fibroblasts. J Cell Physiol 1998: 176: 365-373.
159. Schroeder HE. Ultrastructure of the junctional epithelium of the human gingiva. Helv Odontol Acta 1969: 13: 65-83.
160. Sengelov H. Secretory vesicles of human neutrophils. Eur J Haematol Suppl 1996: 58: 1-24.
161. Shipley JM, Doyle GAR, Fliszar CJYeQ-Z, Johnson LJ, Shapiro SD, Welgus HG, Senior RM. The structural basis for the elastinolytic activity of the 92-kDa and 72-kDa gelatinases. Role of the fibronectin type II-like repeats. J Biol Chem 1996: 271: 4335-4341.
162. Sibraa PD, Reinhardt RA, Dyer JK, DuBois LM. Acute-phase protein detection and quantification in gingival crevicular fluid by direct and indirect immunodot. J Clin Periodontol 1991: 18: 101-106.
163. Sires UI, Murphy G, Baragi VM, Fliszar CJ, Welgus HG, Senior RM. Matrilysin is much more efficient than other matrix metalloproteinases in the proteolytic inactivation of alpha 1-antitrypsin. Biochem Biophys Res Commun
164. Si-Tahar M, Merlin D, Sitaraman S, Madara JL. Constitutive and regulated secretion of secretory leukocyte proteinase inhibitor by human intestinal epithelial cells. Gastroenterology 2000: 118: 1061-1071.
165. Skorstengaard K, Holtet TL, Etzerodt M, Thogersen HC. Collagen-binding recombinant fibronectin fragments containing type II domains. FEBS Lett 1994: 343: 47-50.
166. Sodek J, Hurum S, Feng J. A highly sensitive and specific assay for vertebrate collagenase. J Periodontal Res 1981: 16: 425-433.
167. Sodek J, Overall CM. In: Davidovitch Z, editor. The biological mechanisms of tooth eruption and root resorption. Birmingham, AL: EBSCO, Media, 1988: 303-311.
168. Sorsa T, Ingman T, Suomalainen K, Haapasalo M, Konttinen YT, Lindy O, Saari H, Uitto VJ. Identification of proteases from periodontopathogenic bacteria as activators of latent human neutrophil and fibroblast-type interstitial collagenases. Infect Immun 1992: 60: 4491-4495.
169. Sorsa T, Mäntylä P, Ronka H, Kallio P, Kallis GB, Lundqvist C, Kinane DF, Salo T, Golub LM, Teronen O, Tikanoja S. Scientific basis of a matrix metalloproteinase-8 specific chair-side test for monitoring periodontal and peri-implant health and disease. Ann N Y Acad Sci 1999: 878: 130-140.
170. Springman EB, Angleton EL, Birkedal-Hansen H, Van Wart HE. Multiple modes of activation of latent human fibroblast collagenase, evidence for the role of a Cys73 active-site zinc complex in latency and a 'cysteine switch' mechanism for activation. Proc Natl Acad Sci USA 1990: 87: 364-368.
171. Stams T, Spurlino JC, Smith DL, Wahl RC, Ho TF, Qoronfleh MW, Banks TM, Rubin B. Structure of human neutrophil collagenase reveals large S1′ specificity pocket. Nature Struct Biol 1994: 1: 119-123.
172. Steffensen B, Bigg HF, Overall CM. The involvement of the fibronectin type II-like modules of human gelatinase A in cell surface localization and activation. J Biol Chem 1998: 273: 20622-20628.
173. Steffensen BJ, Wallon UM, Overall CM. Extracellular matrix binding properties of recombinant fibronectin type II-like modules of human 72-kDa gelatinase/type IV collagenase. High affinity binding to native type I collagen but not native type IV collagen. J Biol Chem 1995: 270: 11555-11566.
174. Stocker W, Grams F, Baumann U, Reinemer P, Gomis-Ruth F-X, McKay DB, Bode W. The metzincins - topological and sequential relations between the astacins, adamalysins, serralysins, and matrixins (collagenases) define a superfamily of zinc-peptidases. Protein Sci 1995: 4: 823-840.
175. Sueda T, Bang J, Cimasoni G. Collection of gingival fluid for quantitative analysis. J Dent Res 1969: 48: 159.
176. Sueda T, Imagawa Y, Araya S. Tissue fluid flowing into gingival pocket. Bull Tokyo Med Dent University 1965: 12: 159-167.
177. Sun HB, Smith GN Jr, Hasty KA, Yokota H. Atomic force microscopy-based detection of binding and cleavage site of matrix metalloproteinase on individual type II collagen helices. Anal Biochem 2000: 283: 153-158.
178. Suter S, Chevallier I. Proteolytic inactivation of alpha 1-proteinase inhibitor in infected bronchial secretions from patients with cystic fibrosis. Eur Respir J 1991: 4: 40-49.
179. Svanberg GK. Hydroxyproline titers in gingival crevicular fluid. J Periodontal Res 1987: 22: 212-214.
180. Talonpoika JT, Hämäläinen MM. Type I collagen carboxy-terminal telopeptide in human gingival crevicular fluid in different clinical conditions and after periodontal treatment. J Clin Periodontol 1994: 21: 320-326.
181. Teng YT, Sodek J, McCulloch CA. Gingival crevicular fluid gelatinase and its relationship to periodontal disease in human subjects. J Periodontal Res 1992: 27: 544-552.
182. Tokunaga H, Waguri S, Sato N, Ohsawa Y, Banya Y, Kominami E, Uchiyama Y. Lysosomal cysteine and aspartic proteinases and ubiquitin in rat and human urinary bladder epithelium. Arch Histol Cytol 1996: 59: 249-260.
183. Toomes C, James J, Wood AJ, Wu CL, McCormick D, Lench N, Hewitt C, Moynihan L, Roberts E, Woods CG, Markham A, Wong M, Widmer R, Ghaffar KA, Pemberton M, Hussein IR, Temtamy SA, Davies R, Read AP, Sloan P, Dixon MJ, Thakker NS. Loss-of-function mutations in the cathepsin C gene result in periodontal disease and palmoplantar keratosis. Nat Genet 1999: 23: 421-424.
184. Uitto VJ, Raeste AM. Activation of latent collagenase of human leukocytes and gingival fluid by bacterial plaque. J Dent Res 1978: 57: 844-851.
185. Uitto VJ, Airola K, Vaalamo M, Johansson N, Putnins EE, Firth JD, Salonen J, Lopez-Otin C, Saarialho-Kere U, Kähäri VM. Collagenase-3 (matrix metalloproteinase-13) expression is induced in oral mucosal epithelium during chronic inflammation. Am J Pathol 1998: 152: 1489-1499.
186. Uitto VJ, Larjava H, Heino J, Sorsa T. A protease of Bacteroides gingivalis degrades cell surface and matrix glycoproteins of cultured gingival fibroblasts and induces secretion of collagenase and plasminogen activator. Infect Immun 1989: 57: 213-218.
187. Uitto VJ, Nieminen A, Coil J, Hurttia H, Larjava H. Oral fluid elastase as an indicator of periodontal health. J Clin Periodontol 1996: 23: 30-37.
188. Uitto VJ, Pan YM, Leung WK, Larjava H, Ellen RP, Finlay BB, McBride BC. Cytopathic effects of Treponema denticola chymotrypsin-like proteinase on migrating and stratified epithelial cells. Infect Immun 1995: 63: 3401-3410.
189. Uitto VJ, Raeste AM. Activation of latent collagenase of human leukocytes and gingival fluid by bacterial plaque. J Dent Res 1978: 57: 844-851.
190. Uitto VJ. Degradation of basement membrane collagen by proteinases from human gingiva, leukocytes and bacterial plaque. J Periodontol 1983: 54: 740-745.
191. Uitto VJ, Salonen JI., Firth JD., Jousimies-Somer H., Saarialho-Kere U. Matrilysin (matrix metalloproteinase-7) expression in human junctional epithelium. J Dent Res 2002: 81: 241-246.
192. Vaalamo M, Mattila L, Johansson N, Kariniemi AL, Karjalainen-Lindsberg ML, Kähäri VM, Saarialho-Kere U. Distinct populations of stromal cells express collagenase-3 (MMP-13) and collagenase-1 (MMP-1) in chronic ulcers but not in normally healing wounds. J Invest Dermatol 1997: 109: 96-101.
193. van Wetering S, van der Linden AC, van Sterkenburg MA, de Boer WI, Kuijpers AL, Schalkwijk J, Hiemstra PS. Regulation of SLPI and elafin release from bronchial epithelial cells by neutrophil defensins. Am J Physiol Lung Cell Mol Physiol 2000: 278: 51-58.
194. Vassalli JD, Sappino AE, Belin D. The plasminogen activator/plasmin system. J Clin Invest 1991: 88: 1067-1072.
195. Villela B, Cogen RB, Bartolucci AA, Birkedal-Hansen H. Collagenolytic activity in crevicular fluid from patients with chronic adult periodontitis, localized juvenile periodontitis and gingivitis, and from healthy control subjects. J Periodontal Res 1987: 22: 381-389.
196. Vissers MC, George PM, Bathurst IC, Brennan SO, Winterbourn CC. Cleavage and inactivation of alpha 1-antitrypsin by metalloproteinases released from neutrophils. J Clin Invest 1988: 82: 706-711.
197. Vogelmeier C, Hubbard RC, Fells GA, Schnebli HP, Thompson RC, Fritz H, Crystal RG. Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor. J Clin Invest 1991: 87: 482-488.
198. Wacher MP, Krutzsch HC, Liotta LA, Stetler-Stevenson WG. Development of a novel substrate capture immunoassay for the detection of a neutral metalloproteinase capable of degrading basement membrane (type IV) collagen. J Immunol Meth 1990: 126: 239-245.
199. Waerhaug J. Anatomy, physiology and pathology of the gingival pocket. Rev Belge Med Dent 1966: 21: 9-15.
200. Walakovits LA, Moore VL, Bhardwaj N, Gallick GS, Lark MW. Detection of stromelysin and collagenase in synovial fluid from patients with rheumatoid arthritis and posttraumatic knee injury. Arthritis Rheum 1992: 35: 35-42.
201. Wallaert B, Gressier B, Marquette CH, Gosset P, Remy-Jardin M, Mizon J, Tonnel AB. Inactivation of alpha 1-proteinase inhibitor by alveolar inflammatory cells from smoking patients with or without emphysema. Am Rev Respir Dis 1993: 147: 1537-1543.
202. 2+ for fibronectin and heparin binding. Binding properties of recombinant gelatinase A C domain to extracellular matrix and basement membrane components. J Biol Chem 1997: 272: 7473-7481.
203. Watanabe H, Hattori S, Katsuda S, Nakanishi I, Nagai Y. Human neutrophil elastase: degradation of basement membrane components and immunolocalization in the tissue. J Biochem (Tokyo) 1990: 108: 753-759.
204. Weiss SJ, Peppin G, Ortiz X, Ragsdale C, Test ST. Oxidative autoactivation of latent collagenase by human neutrophils. Science 1985: 227: 747-749.
205. Welch AR, Holman CM, Huber M, Brenner MC, Browner MF Van Wart HE. Understanding the P1′ specificity of the matrix metalloproteinases, effect of S1′ pocket mutations in matrilysin and stromelysin-1. Biochemistry 1996: 35: 10103-10109.
206. Welgus HG, Jeffrey JJ, Stricklin GP, Roswit WT, Eisen AZ. Characteristics of the action of human skin fibroblast collagenase on fibrillar collagen. J Biol Chem 1980: 255: 6806-6813.
207. Werb Z, Tremble PM, Behrendtsen E, Crowley E, Damsky CH. Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression. J Cell Biol 1989: 109: 877-889.
208. Wernicke D, Seyfert C, Hinzmann B, Gromnica-Ihle E. Cloning of collagenase 3 from the synovial membrane and its expression in rheumatoid arthritis and osteoarthritis. J Rheumatol 1996: 23: 590-595.
209. Wilhelm SM, Collier IE, Marmer BL, Eisen AZ, Grant GA, Goldberg GI. SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem 1989: 264: 17213-17221.
210. Wilson CL, Matrisian LM. Matrilysin: an epithelial matrix metalloproteinase with potentially novel functions. Int J Biochem Cell Biol 1996: 28: 123-136.
211. Wilson CL, Ouellette AJ, Satchell DP, Ayabe T, Lopez-Boado YS, Stratman JL, Hultgren SJ, Matrisian LM, Parks WC. Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. Science 1999: 286: 113-117.
212. Windsor LJ, Birkedal-Hansen H, Birkedal-Hansen B, Engler JA. An internal cysteine plays a role in the maintenance of the latency of human fibroblast collagenase. Biochemistry 1991: 30: 641-647.
213. Witko-Sarsat V, Rieu P, Descamps-Latscha B, Lesavre P, Halbwachs-Mecarelli L. Neutrophils: molecules, functions and pathophysiological aspects. Laboratory Invest 2000: 80: 617-653.
214. Woolley DE, Davies RM. Immunolocalization of collagenase in periodontal disease. J Periodontal Res 1981: 16: 292-297.
215. Xiao Y, Bunn CL, Bartold PM. Effect of lipopolysaccharide from periodontal pathogens on the production of tissue plasminogen activator and plasminogen activator inhibitor 2 by human gingival fibroblasts. J Periodontal Res 2001: 36: 25-31.
216. Xu J, Clark RA, Parks WC. p38 mitogen-activated kinase is a bidirectional regulator of human fibroblast collagenase-1 induction by three-dimensional collagen lattices. Biochem J 2001: 355: 437-447.
217. Yin X, Bunn CL, Bartold PM. Detection of tissue plasminogen activator (t-PA) and plasminogen activator inhibitor 2 (PAI-2) in gingival crevicular fluid from healthy, gingivitis and periodontitis patients. J Clin Periodontol 2000: 27: 149-156.
218. Yoshida N. Purification of human neutrophil collagenase, establishment of its monoclonal antibodies and application to gingival crevicular neutrophils. Kokubyo Gakkai Zasshi 1993: 60: 121-310.
219. Yoshida N. Purification of human neutrophil collagenase, establishment of its monoclonal antibodies and application to gingival crevicular neutrophils. Kokubyo Gakkai Zasshi 1993: 60: 121-310.
220. Yu Q, Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev 2000: 14: 163-176.
221. Zucker S, Mancuso P, DiMassimo B, Lysik RM, Conner C, Wu CL. Comparison of techniques for measurement of gelatinases/type IV collagenases: enzyme-linked immunoassays versus substrate degradation assays. Clin Exp Metastasis 1994: 12: 13-23.